RxDoctor Payments Data

Dennis Spratt, MD

Family Medicine · Ottawa, KSNPI 1679509236

Payments from drug & device makers

$4,603in general payments, 2019–2025

Across 293 payments — averaging $15.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$718
  • Novo Nordisk$659
  • Lilly USA, LLC$409
  • Merck$205
  • AstraZeneca$203
  • Boehringer Ingelheim$202
  • plus $2K from 40 others

What the payments were for

  • Food & beverage$4,51398%
  • Education$902%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,603 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$72,883
Medicare patients
446
Services billed
5,862

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban90$54,880
XareltoRivaroxaban23$25,162
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$24,553
MounjaroTirzepatide17$23,237
JardianceEmpagliflozin26$16,713
MyrbetriqMirabegron31$15,769
TrulicityDulaglutide16$14,671
OzempicSemaglutide12$11,570
Breo ElliptaFluticasone/Vilanterol16$9,505
Tresiba Flextouch U-100Insulin Degludec12$6,850
Potassium Chloride261$6,373
TrintellixVortioxetine Hydrobromide12$5,778
BrilintaTicagrelor11$4,342
Atorvastatin Calcium588$4,143
Gabapentin284$3,708

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$155$54,88090 claims
Lilly USA, LLCMounjaro, Trulicity$409$37,90833 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$88$36,26665 claims
Johnson & JohnsonXarelto$172$25,16223 claims
Boehringer IngelheimJardiance$202$16,71326 claims
Astellas Pharma US IncMyrbetriq$89$15,76931 claims
Novo NordiskOzempic$659$11,57012 claims
AstraZenecaBrilinta$203$4,34211 claims
AbbVieSynthroid$718$1,86332 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Ottawa

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →